Search
Diffuse Midline Glioma, H3 K27M-Mutant
go.drugbank.com/conditions/DBCOND0092211Drugs: DordaviproneSynonyms: Diffuse midline glioma, point mutation K27M in histone H3 (morphologic abnormality)Fatigue
go.drugbank.com/conditions/DBCOND0012333Synonyms: Lacking in energy, Lacking in energy (finding)Acyclovir
go.drugbank.com/drugs/DB00787ApprovedInvestigational[L7303,L7315,L7318,L7321,L7324,L7327] Acyclovir is generally used first line in the treatment of these viruses and some products are indicated for patients as young as 6 years old. … [L7321] Acyclovir was granted FDA approval on 29 March 1982.[L7318]
Products: AVIREX-I, ZOVIRAX IVCognitive Impairment (CI)
go.drugbank.com/conditions/DBCOND0138824Drugs: PiracetamSynonyms: Disturbance in cognitionRelapsed Acute Myelogenous Leukemia (AML)
go.drugbank.com/conditions/DBCOND0069493Synonyms: Acute Myelogenous Leukemia in RelapseSleeping Disorders
go.drugbank.com/conditions/DBCOND0148601Synonyms: Disturbance in sleep behavior, NOS, Disturbance in sleep behavior (finding)Povidone-iodine
go.drugbank.com/drugs/DB06812ApprovedInvestigationalDuring in vitro testing to demonstrate anti-bacterial activity it was found that the complex was less toxic in mice than tincture of iodine. … This unique complex was discovered in 1955 at the Industrial Toxicology Laboratories in Philadelphia by H. A. Shelanski and M. V. Shelanski.
Mixtures: BRAUNODERM (IN 250ML AND 1000ML PLASTIC), IV Infusion CPICategories: Compounds used in a research, industrial, or household settingFluocinolone acetonide
go.drugbank.com/drugs/DB00591ApprovedInvestigationalVet approved[T357] It has been used extensively in dermatological preparations and it has also been investigated thoroughly for its use in implantable corticosteroid devices. … [T358] This type of device containing fluocinolone acetonide was developed by Taro Pharmaceuticals and approved by FDA in May 2016.[L4676]
Mixtures: OCIDERM-N, CINOLON-NProducts: ILUVIEN 190 Mikrogramm intravitreales Implantat im ApplikatorMeloxicam
go.drugbank.com/drugs/DB00814ApprovedInvestigationalVet approved[A190189] With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations. … It is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.[A190198,A190201]
Products: BIENEX INY®, EXEN 15 MG/1.5 ML IM ENJEKSİYONLUK ÇÖZELTİ, 3 AMPULFacial Angiofibroma
go.drugbank.com/conditions/DBCOND0063101Drugs: SirolimusSynonyms: Angiokeratoma in tuberous sclerosis